193 results
Page 6 of 10
425
hynq8m8fzg7f7pk3nywn
1 Nov 18
Business combination disclosure
5:00pm
8-K
EX-2.1
wcf3i3l21z4v1s7qwiu
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
knytc6f
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.3
btydchkrk6u8h hj
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.1
pughx4
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
45w kitvk
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.4
q63e91p1
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-3.1
cac6nc1g4m ty
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-99.3
bjbq6y99q7o
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.1
w80f 6uj4nfa0
9 Aug 18
Business combination disclosure
5:17pm
425
EX-3.1
476wi6my63
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.4
xl6vedy czcxmlc1
9 Aug 18
Business combination disclosure
5:17pm
425
1ykw9dqh
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
9br0bahmxn9 vnmz
9 Aug 18
Business combination disclosure
5:17pm
425
EX-2.1
jig9vdo
9 Aug 18
Business combination disclosure
5:17pm
DEFA14A
dbk6cmvw ipaxeab0
30 Apr 18
Additional proxy soliciting materials
4:59pm